Cargando…
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Emergence of SARS-CoV-2 variants diminishes the efficacy of vaccines and antiviral monoclonal antibodies. Continued development of immunotherapies and vaccine immunogens resilient to viral evolution is therefore necessary. Using coldspot-guided antibody discovery, a screening approach that focuses o...
Ejemplares similares
-
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
por: Bianchini, Filippo, et al.
Publicado: (2022) -
Analytical Ultracentrifugation Detects Quaternary Rearrangements and Antibody-Induced Conformational Selection of the SARS-CoV-2 Spike Trimer
por: Guerrini, Giuditta, et al.
Publicado: (2023) -
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
por: Muri, Jonathan, et al.
Publicado: (2022) -
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
por: Muri, Jonathan, et al.
Publicado: (2023) -
Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
por: De Gasparo, Raoul, et al.
Publicado: (2021)